Clinical Study

A Randomized Phase III Study Of Sublobar Resection (Sr) Versus Stereotactic Ablative Radiotherapy (Sabr) In High Risk Patients With Stage I Non-Small Cell Lung Cancer (Nsclc)

Posted Date: Dec 12, 2017

  • Investigator: Sandra Starnes
  • Specialties: Hematology/Oncology, Oncology, Cancer
  • Type of Study: Drug

The purpose of this study is to compare the results of two standard treatments. The two treatments include sublobar resection and radiation. Sublobar resection is the removal of a small portion of a lung. Radiation, orstereotactic ablative radiotherapy, is radiation given by a specialized x-ray machine that targets your lung cancer.

Criteria:

To Be Eligible To Participate In This Study, Participants Must Have Lung Cancer, Or A Lung Nodule Suspicious For Lung Cancer Which May Be Removable With Surgery. Typically This Is Done By Removing A Lobe Of The Lung. Due To Certain Risks, You Would Require A Surgery Removing A Smaller Portion Of The Lung.

Keywords:

Phase Iii, Stu-022015-069, Lung, Non-Small Cell Lung Cancer, Cancer

For More Information:

Uc Cancer Institute
513-584-7698
cancer@uchealth.com